OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION

LIVE

Serial Number

90733729

Owner

Novartis AG

Attorney

Maury M. Tepper, III

First Use Date

Oct 1, 2020

Filing Date

May 25, 2021

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION Trademark

Serial Number: 90733729 • Registration: 8005173

OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION is a trademark filed by Novartis AG on May 25, 2021. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Trademark Classes

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Novartis AG (17 trademarks)

CH-4002 Basel

Entity Type: 03

Legal Representation

Attorney of Record

Maury M. Tepper, III

5,883 trademarks filed View all →

Correspondence Address

Maury M. Tepper, III TEPPER & EYSTER, PLLC

3724 BENSON DR

RALEIGH, NC 27609

United States

Trademark Details

Filing Date

May 25, 2021

Registration Date

October 28, 2025

First Use Anywhere

October 1, 2020

First Use in Commerce

October 1, 2020

Published for Opposition

August 16, 2022

Goods & Services

Providing health information

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 28, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Oct 28, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 8, 2025 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 8, 2025 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Oct 7, 2025 SUPC

USE AMENDMENT FILED

Oct 6, 2025 IUAF

TEAS STATEMENT OF USE RECEIVED

Oct 6, 2025 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 23, 2025 EXRA

SOU EXTENSION 5 GRANTED

Jul 23, 2025 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jul 23, 2025 AITU

SOU TEAS EXTENSION RECEIVED

Apr 8, 2025 EEXT

SOU EXTENSION 5 FILED

Apr 7, 2025 EXT5

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 7, 2024 EXRA

SOU EXTENSION 4 GRANTED

Oct 7, 2024 EX4G

SOU EXTENSION 4 FILED

Oct 7, 2024 EXT4

SOU TEAS EXTENSION RECEIVED

Oct 7, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 2, 2024 EXRA

SOU EXTENSION 3 GRANTED

Mar 30, 2024 EX3G

SOU EXTENSION 3 FILED

Mar 30, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Mar 30, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 4, 2023 EXRA

SOU EXTENSION 2 GRANTED

Oct 2, 2023 EX2G

SOU EXTENSION 2 FILED

Oct 2, 2023 EXT2

SOU TEAS EXTENSION RECEIVED

Oct 2, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 12, 2023 EXRA

SOU EXTENSION 1 GRANTED

Apr 10, 2023 EX1G

SOU EXTENSION 1 FILED

Apr 10, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Apr 10, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 11, 2022 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 16, 2022 NPUB

PUBLISHED FOR OPPOSITION

Aug 16, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 27, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 12, 2022 CNSA

EXAMINER'S AMENDMENT ENTERED

Jul 12, 2022 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 12, 2022 GNEN

EXAMINERS AMENDMENT E-MAILED

Jul 12, 2022 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jul 12, 2022 CNEA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 7, 2022 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 6, 2022 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 6, 2022 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 14, 2022 GNRN

NON-FINAL ACTION E-MAILED

Mar 14, 2022 GNRT

NON-FINAL ACTION WRITTEN

Mar 14, 2022 CNRT

ASSIGNED TO EXAMINER

Mar 3, 2022 DOCK

ASSIGNED TO EXAMINER

Feb 8, 2022 DOCK

ASSIGNED TO EXAMINER

Feb 7, 2022 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Aug 21, 2021 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 20, 2021 NWOS

NEW APPLICATION ENTERED

May 28, 2021 NWAP

Related Trademarks

More from this Owner

More in Same Class

POSH

THROUGH THE FOREST COUNSELING

NAGASTE

B/H

CONNECTED HOME LIVING

METHUEN PEDIATRIC THERAPY